JP2011509287A5 - - Google Patents

Download PDF

Info

Publication number
JP2011509287A5
JP2011509287A5 JP2010541885A JP2010541885A JP2011509287A5 JP 2011509287 A5 JP2011509287 A5 JP 2011509287A5 JP 2010541885 A JP2010541885 A JP 2010541885A JP 2010541885 A JP2010541885 A JP 2010541885A JP 2011509287 A5 JP2011509287 A5 JP 2011509287A5
Authority
JP
Japan
Prior art keywords
protein
peptide
polysaccharide
oil
pharmaceutical composition
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2010541885A
Other languages
English (en)
Japanese (ja)
Other versions
JP5432183B2 (ja
JP2011509287A (ja
Filing date
Publication date
Priority claimed from IL188647A external-priority patent/IL188647A0/en
Application filed filed Critical
Publication of JP2011509287A publication Critical patent/JP2011509287A/ja
Publication of JP2011509287A5 publication Critical patent/JP2011509287A5/ja
Application granted granted Critical
Publication of JP5432183B2 publication Critical patent/JP5432183B2/ja
Expired - Fee Related legal-status Critical Current
Anticipated expiration legal-status Critical

Links

JP2010541885A 2008-01-08 2009-01-08 タンパク質およびペプチドの治療薬の経口投与に関する方法および組成物 Expired - Fee Related JP5432183B2 (ja)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
IL188647A IL188647A0 (en) 2008-01-08 2008-01-08 Adaptable structured drug and supplements administration system (for oral and/or transdermal applications)
IL188647 2008-01-08
US8029508P 2008-07-14 2008-07-14
US61/080,295 2008-07-14
PCT/IL2009/000036 WO2009087633A2 (en) 2008-01-08 2009-01-08 Methods and compositions for oral administration of protein and peptide therapeutic agents

Publications (3)

Publication Number Publication Date
JP2011509287A JP2011509287A (ja) 2011-03-24
JP2011509287A5 true JP2011509287A5 (cg-RX-API-DMAC7.html) 2012-03-01
JP5432183B2 JP5432183B2 (ja) 2014-03-05

Family

ID=40326402

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2010541885A Expired - Fee Related JP5432183B2 (ja) 2008-01-08 2009-01-08 タンパク質およびペプチドの治療薬の経口投与に関する方法および組成物

Country Status (15)

Country Link
US (3) US8936786B2 (cg-RX-API-DMAC7.html)
EP (2) EP2254590B1 (cg-RX-API-DMAC7.html)
JP (1) JP5432183B2 (cg-RX-API-DMAC7.html)
KR (1) KR101588066B1 (cg-RX-API-DMAC7.html)
AU (2) AU2009203530B2 (cg-RX-API-DMAC7.html)
BR (1) BRPI0906866A2 (cg-RX-API-DMAC7.html)
CA (2) CA2711554C (cg-RX-API-DMAC7.html)
DK (2) DK2231123T3 (cg-RX-API-DMAC7.html)
EA (1) EA018461B1 (cg-RX-API-DMAC7.html)
ES (2) ES2397061T3 (cg-RX-API-DMAC7.html)
IL (3) IL188647A0 (cg-RX-API-DMAC7.html)
MX (1) MX2010007462A (cg-RX-API-DMAC7.html)
NZ (1) NZ586374A (cg-RX-API-DMAC7.html)
WO (2) WO2009087634A2 (cg-RX-API-DMAC7.html)
ZA (1) ZA201004480B (cg-RX-API-DMAC7.html)

Families Citing this family (23)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2521295Y2 (ja) 1991-11-13 1996-12-25 シーケーディ株式会社 流体混合器
IL188647A0 (en) * 2008-01-08 2008-11-03 Orina Gribova Adaptable structured drug and supplements administration system (for oral and/or transdermal applications)
IN2012DN00311A (cg-RX-API-DMAC7.html) * 2009-07-09 2015-05-08 Oshadi Drug Administration Ltd
UY34054A (es) * 2011-05-02 2012-11-30 Millennium Pharm Inc FORMULACIÓN PARA ANTICUERPO ANTI-a(alfa)4B(Beta)7
WO2013114371A1 (en) 2012-02-01 2013-08-08 Protalix Ltd. Dry powder formulations of dnase i
US20140057856A1 (en) * 2012-08-22 2014-02-27 The Regents Of The Universtiy Of California Compositions and Methods For Enhancing Sialic Acid Levels In Tissue
US10835495B2 (en) 2012-11-14 2020-11-17 W. R. Grace & Co.-Conn. Compositions containing a biologically active material and a non-ordered inorganic oxide material and methods of making and using the same
EP2950809A4 (en) * 2013-01-29 2016-09-14 Oshadi Drug Administration Ltd PHARMACEUTICAL COMPOSITIONS FOR THE ORAL TREATMENT OF DIABETES
ES2502691B1 (es) * 2013-09-25 2015-07-07 Sani-Red, S.L. Método de conservación y estabilización de proteínas, aplicable para desarrollos industriales de formulaciones de productos sanitarios, farmacéuticos y cosméticos
US9474720B2 (en) 2013-11-04 2016-10-25 BioPharmX, Inc. Dosage form comprising an active ingredient and a plurality of solid porous microcarriers
US9168211B2 (en) * 2014-03-28 2015-10-27 Johnson & Johnson Consumer Inc. Method of making an anhydrous, pigmented composition
KR102418550B1 (ko) * 2015-11-03 2022-07-06 삼성전자주식회사 포토 레지스트 패턴 형성 방법 및 이를 이용한 반도체 장치 제조 방법
US10660941B2 (en) 2016-02-19 2020-05-26 Indian Institute Of Technology, Bombay Orally administrable pharmaceutical preparation containing protein
RU2718554C1 (ru) * 2017-09-25 2020-04-08 Георгий Георгиевич Чумбуридзе Термостабильная композиция, обладающая антивирусной и антибактериальной активностью и ее использование
IT201800007947A1 (it) * 2018-08-07 2020-02-07 Vetagro Int Srl Metodo per preparare una composizione di aminoacidi per consentire la corrispondenza dei singoli fabbisogni di amminoacidi ad un soggetto in base all'età, al genere, all'attività fisica e alla genetica
SG11202111251SA (en) 2019-04-11 2021-11-29 R P Scherer Technologies Llc Formulation for oral delivery of proteins, peptides and small molecules with poor permeability
US20220296683A1 (en) * 2019-09-20 2022-09-22 University College Dublin Oral delivery system
MX2022007326A (es) 2019-12-17 2022-09-23 9286 3620 Quebec Inc Sistemas de suministro oral basados en la formacion in situ de coacervados de proteínas polisacáridos.
AU2021213767A1 (en) 2020-01-28 2022-07-28 Genentech, Inc. IL15/IL15R alpha heterodimeric Fc-fusion proteins for the treatment of cancer
JP2023534810A (ja) 2020-07-15 2023-08-14 シャバー リサーチ アソシエイツ エルエルシー 急性痛の処置並びに胸やけの重症度及び/又はリスクの低減のための、イブプロフェン及びファモチジンから構成される単位経口用量組成物
EP4369942A1 (en) 2021-07-12 2024-05-22 Zidkiyahu Simenhaus Protein containing bio-active compositions comprising cellulose microparticle carriers
CN119630685A (zh) 2022-06-13 2025-03-14 B.A.I.实验室有限责任公司 结合白介素-13的环状寡肽及其使用方法
WO2026125835A1 (fr) 2024-12-13 2026-06-18 Biomerieux Capsule et procédé de compartimentation de particules d'extraction dans un contenant

Family Cites Families (59)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3252859A (en) * 1962-10-24 1966-05-24 Masti Kure Company Inc Colloidal silica-oil composition and method of using same
US6551576B1 (en) 1989-12-22 2003-04-22 Bristol-Myers Squibb Medical Imaging, Inc. Container with multi-phase composition for use in diagnostic and therapeutic applications
ES2027518A6 (es) 1990-12-18 1992-06-01 Andromaco Lab Procedimiento para la preparacion de nuevas asociaciones no covalentes polisacarido-proteina con actividad farmacologica.
US5145684A (en) * 1991-01-25 1992-09-08 Sterling Drug Inc. Surface modified drug nanoparticles
US5260002A (en) * 1991-12-23 1993-11-09 Vanderbilt University Method and apparatus for producing uniform polymeric spheres
US7083572B2 (en) 1993-11-30 2006-08-01 Bristol-Myers Squibb Medical Imaging, Inc. Therapeutic delivery systems
US20040018236A1 (en) 1995-05-08 2004-01-29 Robert Gurny Nanoparticles for oral administration of pharmaceutical agents of low solubility
ES2093562B1 (es) 1995-05-26 1997-07-01 Univ Santiago Compostela Estabilizacion de sistemas coloidales mediante formacion de complejos ionicos lipido-polisacarido.
US5874105A (en) * 1996-01-31 1999-02-23 Collaborative Laboratories, Inc. Lipid vesicles formed with alkylammonium fatty acid salts
US6071535A (en) * 1996-01-31 2000-06-06 Collaborative Laboratories, Inc. Lipid vesicles formed with alkylammonium fatty acid salts
US6322765B1 (en) * 1996-02-15 2001-11-27 Wacker-Chemie Gmbh Process for preparing silicon dioxide
US6120751A (en) 1997-03-21 2000-09-19 Imarx Pharmaceutical Corp. Charged lipids and uses for the same
US20020039594A1 (en) 1997-05-13 2002-04-04 Evan C. Unger Solid porous matrices and methods of making and using the same
US6171586B1 (en) * 1997-06-13 2001-01-09 Genentech, Inc. Antibody formulation
FR2767718B1 (fr) * 1997-08-28 1999-10-22 Oreal Emulsion eau-dans-huile comprenant de la silice pyrogenee et un alkylether de polysaccharide
TR199901008T1 (xx) 1997-09-09 2000-02-21 Select Release, L.C. Kaplanm�� partik�ller, yap�m� ve kullan�m y�ntemleri.
US6638621B2 (en) * 2000-08-16 2003-10-28 Lyotropic Therapeutics, Inc. Coated particles, methods of making and using
FR2773804B1 (fr) * 1998-01-19 2000-02-18 Sanofi Sa Polysaccharides de synthese, procede pour leur preparation et compositions pharmaceutiques le contenant
US6656922B2 (en) 1998-05-28 2003-12-02 Mediplex Corporation, Korea Oral delivery of macromolecules
MX339071B (es) 1999-03-31 2016-05-09 Janssen Pharmaceutica Nv Almidon pregelatinizado en una formulacion de liberacion controlada.
US6458387B1 (en) * 1999-10-18 2002-10-01 Epic Therapeutics, Inc. Sustained release microspheres
US7195780B2 (en) 2002-10-21 2007-03-27 University Of Florida Nanoparticle delivery system
DE10001172A1 (de) 2000-01-13 2001-07-26 Max Planck Gesellschaft Templatieren von Feststoffpartikeln mit Polymermultischichten
JP4631119B2 (ja) * 2000-01-28 2011-02-16 Jsr株式会社 疎水化コロイダルシリカの製造方法
US7067116B1 (en) 2000-03-23 2006-06-27 Warner-Lambert Company Llc Fast dissolving orally consumable solid film containing a taste masking agent and pharmaceutically active agent at weight ratio of 1:3 to 3:1
US6548264B1 (en) * 2000-05-17 2003-04-15 University Of Florida Coated nanoparticles
NZ523017A (en) * 2000-06-29 2004-10-29 Emisphere Tech Inc Compounds and compositions for delivering active agents and preparation method thereof
DE50012404D1 (de) * 2000-08-11 2006-05-11 Lohmann Animal Health Gmbh W/o Emulsion Adjuvanszuzammensetzungen für Impstoffen
WO2002032398A2 (en) * 2000-10-16 2002-04-25 Massachusetts Institute Of Technology Lipid-protein-sugar particles for drug delivery
FR2819720B1 (fr) 2001-01-22 2004-03-12 Fournier Lab Sa Nouveaux comprimes de fenofibrate
US6698247B2 (en) 2001-05-04 2004-03-02 Corning Incorporated Method and feedstock for making silica by flame combustion
US6828297B2 (en) 2001-06-04 2004-12-07 Nobex Corporation Mixtures of insulin drug-oligomer conjugates comprising polyalkylene glycol, uses thereof, and methods of making same
WO2003055469A1 (en) * 2001-12-21 2003-07-10 Celator Technologies Inc. Improved polymer-lipid delivery vehicles
WO2003043586A2 (en) * 2001-11-20 2003-05-30 Advanced Inhalation Research, Inc. Compositions for sustained action product delivery
US20030235619A1 (en) 2001-12-21 2003-12-25 Christine Allen Polymer-lipid delivery vehicles
US20030198666A1 (en) * 2002-01-07 2003-10-23 Richat Abbas Oral insulin therapy
US6824790B2 (en) 2002-01-09 2004-11-30 Enzrel Inc. Liposome drug delivery of polycyclic, aromatic, antioxidant or anti-inflammatory compounds
WO2003066859A2 (en) 2002-02-07 2003-08-14 Yissum Research Development Company Of The Hebrew University Of Jerusalem Amino acid sequences capable of facilitating penetration across a biological barrier
US7244498B2 (en) 2002-06-12 2007-07-17 Tda Research, Inc. Nanoparticles modified with multiple organic acids
US7090868B2 (en) * 2002-09-13 2006-08-15 University Of Florida Materials and methods for drug delivery and uptake
US7384914B2 (en) 2003-01-06 2008-06-10 Emisphere Technologies, Inc. Night-time oral insulin therapy
US20040242729A1 (en) 2003-05-30 2004-12-02 3M Innovative Properties Company Stabilized particle dispersions containing surface-modified inorganic nanoparticles
AU2004317954A1 (en) 2003-09-17 2005-10-13 Chiasma, Inc. Compositions capable of facilitating penetration across a biological barrier
JP2007509981A (ja) * 2003-10-31 2007-04-19 テバ ファーマシューティカル インダストリーズ リミティド 薬物デリバリー用ナノ粒子
KR100638041B1 (ko) * 2003-12-24 2006-10-23 주식회사 삼양사 수용성 약물의 경구투여용 나노입자 조성물 및 그의제조방법
CA2563533C (en) 2004-04-15 2013-10-01 Shmuel A. Ben-Sasson Compositions capable of facilitating penetration across a biological barrier
US7288134B2 (en) 2004-09-10 2007-10-30 International Business Machines Corporation Dumbbell-like nanoparticles and a process of forming the same
US7282194B2 (en) * 2004-10-05 2007-10-16 Gp Medical, Inc. Nanoparticles for protein drug delivery
WO2006044660A2 (en) * 2004-10-14 2006-04-27 Vanderbilt University Functionalized solid lipid nanoparticles and methods of making and using same
WO2006062506A1 (en) 2004-12-03 2006-06-15 Enzrel, Inc. Chitosan-coated liposome drug delivery of antioxidant or anti-inflammatory compounds
JP4920685B2 (ja) * 2005-08-09 2012-04-18 ユニヴァーシティ・オヴ・サンダーランド 質量分析を使用する指紋分析
ES2761937T3 (es) 2005-10-24 2020-05-21 Magsense Life Sciences Inc Método para preparar micropartículas recubiertas con polímero
US20070104778A1 (en) 2005-11-07 2007-05-10 Hongxia Zeng Controlled-release emulsion compositions
WO2008048288A2 (en) * 2005-11-09 2008-04-24 Montana State University Novel nanoparticles and use thereof
US20070134332A1 (en) 2005-11-21 2007-06-14 Medivas, Llc Polymer particles for delivery of macromolecules and methods of use
US20070184076A1 (en) * 2006-02-07 2007-08-09 Unger Evan C Liquid-filled nanodroplets for anti-cancer therapy
WO2007121256A2 (en) * 2006-04-12 2007-10-25 Biodel, Inc. Rapid acting and long acting insulin combination formulations
IL188647A0 (en) 2008-01-08 2008-11-03 Orina Gribova Adaptable structured drug and supplements administration system (for oral and/or transdermal applications)
IN2012DN00311A (cg-RX-API-DMAC7.html) * 2009-07-09 2015-05-08 Oshadi Drug Administration Ltd

Similar Documents

Publication Publication Date Title
JP5841708B2 (ja) 表面被覆微粒子の医薬組成物
Rodrigues et al. Recent applications of starch derivatives in nanodrug delivery
JP5581227B2 (ja) 硝子体内注射のための低粘度、高凝集トリアムシノロンアセトニド懸濁剤
KR20180129990A (ko) 골수종의 치료
WO1999033491A1 (fr) Compositions medicinales a liberation prolongee
EP2997077A1 (en) Collagen powder, composition and use
CN1556712A (zh) 含dds化合物的药用组合物
JP2012531442A5 (cg-RX-API-DMAC7.html)
JP2011519867A5 (cg-RX-API-DMAC7.html)
JP2002348234A (ja) 薬物封入無機物微粒子、その製造法及び薬物封入無機物微粒子製剤
JP2004075662A (ja) 徐放性組成物、その製造方法およびその製剤
JP2011509287A (ja) タンパク質およびペプチドの治療薬の経口投与に関する方法および組成物
KR20120084303A (ko) 약물 함유 미립자를 포함하는 의약 조성물 및 그 제조 방법
KR20220134781A (ko) 천연 중합체에 기반한 패치 제품
CN104027808B (zh) 一种抗脉管性疾病及抗肿瘤的药物组合物及其应用
AU2021308083A1 (en) Preparations and compositions comprising polymer combination preparations
EP3678706A1 (en) Albumin-modified nanoparticles carrying a targeting ligand
JP2006199589A (ja) 生理活性タンパク質またはペプチドを含有するナノ粒子およびその製造方法、ならびに当該ナノ粒子からなる外用剤
CN104288093A (zh) 纳米药物透皮制剂在肿瘤中的应用
Devrim et al. Preparation and evaluation of PLGA microparticles as carrier for the pulmonary delivery of rhIL-2: I. Effects of some formulation parameters on microparticle characteristics
JPH10513202A (ja) キトサン薬物送達システム
CN107126564A (zh) 一种白蛋白结合型索拉非尼纳米制剂及其制备方法
KR100908517B1 (ko) 호흡기계 약제 전달을 위한 서방형 다공성 미세입자 및 그제조 방법
US20170290947A1 (en) Micronized hydrophilic cross-linked biopolymer systems and method of making same
US11793758B2 (en) Formulations of biological polymers for oral administration